Modiwart (Imiquimod)

Imiquimod, the active ingredient in Modiwart, is an immune response modifier presented as a topical formulation for cutaneous use. It is applied to the skin to treat precancerous lesions and certain viral skin conditions in adult patients.

GNH USA supplies Modiwart as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows EU quality standards and provides regulatory‑compliant shipments to global markets.

Imiquimod is used in dermatology to target abnormal skin growths and viral lesions.

- Actinic keratosis: reduces and eliminates precancerous skin lesions. - Superficial basal cell carcinoma: promotes clearance of early‑stage skin cancer. - External genital warts: induces immune‑mediated regression of HPV‑related warts.

Topical imiquimod may cause local and systemic reactions, most of which are mild to moderate.

Common Side Effects: - Redness: localized erythema at the application site. - Itching: mild to moderate pruritus. - Burning sensation: transient heat feeling. - Swelling: edema of the treated area. - Crusting or scaling: formation of dry scabs. - Pain: discomfort or tenderness at the site.

Serious or Rare Side Effects: - Severe allergic reaction: signs of anaphylaxis such as difficulty breathing or facial swelling. - Extensive skin ulceration: deep necrosis or persistent ulceration beyond the treated area. - Systemic flu‑like symptoms: fever, chills, headache or malaise. - Pigmentary changes: persistent hypopigmentation or hyperpigmentation of the skin.

When using Modiwart, follow prescriber guidance and observe safety measures.

- Application frequency: follow prescriber instructions, typically once daily or as directed. - Treatment area: limit use to prescribed lesions; avoid healthy skin. - Sun exposure: protect treated skin from UV radiation to reduce irritation. - Pregnancy and lactation: use only if potential benefit justifies risk; consult healthcare provider. - Concomitant skin products: avoid using other topical medications or cosmetics on the same area unless approved. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Imiquimod may interact with other agents that affect immune function or skin integrity.

Major Interactions (Avoid): - Systemic immunosuppressants: may diminish imiquimod’s efficacy. - Live vaccines: increased risk of infection due to immune modulation.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: can reduce local immune response and affect treatment outcome. - Antiviral agents applied to same site: potential for altered absorption. - Phototherapy: may increase skin irritation when combined. - Herbal skin preparations: possible additive irritation.